Ftse Mib
34.136,19
-0,70%
DAX
18.470,19
-0,70%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.993,36
-2,87%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
21/03/201801:30PR Newswire (US)BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe WeatherAMEX:BPMXBioPharmX Corporation
20/03/201814:15PR Newswire (US)U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug CompositionsAMEX:BPMXBioPharmX Corporation
14/03/201814:15PR Newswire (US)BioPharmX to Present at Oppenheimer's 28th Annual Healthcare ConferenceAMEX:BPMXBioPharmX Corporation
13/03/201811:11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
09/03/201822:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
05/03/201815:15PR Newswire (US)BioPharmX to Present at 30th Annual ROTH ConferenceAMEX:BPMXBioPharmX Corporation
14/02/201816:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
26/01/201815:15PR Newswire (US)BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocy...AMEX:BPMXBioPharmX Corporation
25/01/201814:05InvestorsHub NewsWireTraders News Source Issues Stocks on Watch and a New Feature ReportAMEX:BPMXBioPharmX Corporation
12/01/201815:15PR Newswire (US)BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This MonthAMEX:BPMXBioPharmX Corporation
12/12/201722:19Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
07/12/201722:15PR Newswire (US)BioPharmX Reports Third Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
04/12/201715:15PR Newswire (US)BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Tr...AMEX:BPMXBioPharmX Corporation
30/11/201723:33Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
22/11/201712:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)AMEX:BPMXBioPharmX Corporation
21/11/201715:05PR Newswire (US)BioPharmX Corporation Announces Pricing of Public OfferingAMEX:BPMXBioPharmX Corporation
21/11/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
20/11/201723:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
08/11/201715:15PR Newswire (US)BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study PlansAMEX:BPMXBioPharmX Corporation
23/10/201722:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
19/10/201723:29Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BPMXBioPharmX Corporation
18/10/201716:30PR Newswire (US)BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017AMEX:BPMXBioPharmX Corporation
11/10/201716:30PR Newswire (US)BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Dru...AMEX:BPMXBioPharmX Corporation
13/09/201715:00PR Newswire (US)BioPharmX Reports Second Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
12/09/201713:30PR Newswire (US)BioPharmX Announces Preliminary Data from Rosacea Feasibility StudyAMEX:BPMXBioPharmX Corporation
05/09/201715:15PR Newswire (US)BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment ConferenceAMEX:BPMXBioPharmX Corporation
17/08/201722:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
08/08/201720:43Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
27/07/201715:15PR Newswire (US)Summer AAD Panel to Discuss BPX-01 for Acne and RosaceaAMEX:BPMXBioPharmX Corporation
24/07/201712:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
ENI
Eni
BIT
AMP
Amplifon
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
G
Generali
BIT
STMMI
ST Microelectronics
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network